The ferroptosis inducer withaferin A and the CXCL10/CXCR2 axis inhibitor SB225002 can significantly restrain HCC metastasis and improve the prognosis of anti-PD-1 treatment[64]. This evidence concerns the gene CXCL10 and hepatocellular carcinoma.